Different title developer EpiPen is undervalued regardless of robust medical information, analyst sees enormous upside potential

Cantor initiated protection on Acetive Therapeutics, Inc.. (NASDAQ:LQST), a pharmaceutical firm that markets 5 merchandise.

The corporate additionally collaborates with pharmaceutical corporations to commercialize new molecules utilizing its applied sciences, reminiscent of PharmFilm. The query is move forward a late-stage proprietary product candidate for extreme allergic reactions, together with anaphylaxis, and an early-stage topical epinephrine prodrug gel for numerous dermatologic situations.

Cantor factors out that the corporate’s secret sauce is PharmFilm know-how, which delivers energetic pharmaceutical elements orally (e.g. buccal, sublingual and lingual). The primary focus of the story proper now could be Anaphylm, which is in pre-NDA growth for kind 1 allergic reactions.

Cantor begins with an obese score and a $17 price prediction.

Learn additionally: Optimism around Aquestive as he moves forward with severe allergy and candidate for baldness

Earlier this month, the corporate reaffirmed the Q1 2025 New Drug Software submission pointers for Anaphylm and confirmed that no extra grownup medical trials are required previous to NDA submission . The corporate started pediatric trials in the United States and Canada.

Cantor writes that Aquestive’s shares are buying and selling properly beneath the estimated peak gross sales for Anaphylm, though the corporate has produced important information supporting its comparable profile to epinephrine auto-injectors (and, in some conditions, enhancements).

“We’d be patrons on the potential of this program alone and imagine shares might rise over 200% in 2025 if authorised,” the Cantor analyst writes.

Cantor writes that Anaphylm’s sublingual epinephrine might disrupt the epinephrine auto-injector market:

• The product may be very moveable, concerning the measurement of a postage stamp, and might slot in a pocket or behind a mobile phone.

• It could possibly be faster and simpler to make use of than conventional auto-injectors, with fewer steps to comply with, which might make it extra engaging to sufferers and caregivers.

The submission of Anaphylm’s U.S. advertising software makes up the majority of Cantor’s income forecast for Aquestive.

Value motion: AQST inventory is up 7.31% at $3.86 ultimately test Tuesday.

Learn subsequent:

Picture: Shutterstock/Andrey_Popov.

View more analyst ratings for AQST

View the latest analyst ratings

UNLOCKED: 5 NEW PROFESSIONS EVERY WEEK. Click now to get daily best business ideasplus limitless entry to cutting-edge instruments and methods to realize an edge within the markets.

The story continues